Breast cancer and "chemobrain": the consequences of cognitive difficulties following chemotherapy and the potential for recovery
- PMID: 19397112
Breast cancer and "chemobrain": the consequences of cognitive difficulties following chemotherapy and the potential for recovery
Abstract
Up to one-third of women breast cancer survivors report difficulties with concentration, multi-tasking, and memory. Research in the University of Missouri, Department of Health Psychology, suggests that these cognitive difficulties are associated with poorer quality of life among breast cancer survivors after treatment. This article discusses this treatment side effect and its consequences for daily functioning, highlights ongoing research on the potential role of stress in the development of cognitive difficulties, and reviews treatment options.
Similar articles
-
Cognitive side-effects of adjuvant treatments.Breast. 2007 Dec;16 Suppl 2:S166-8. doi: 10.1016/j.breast.2007.07.027. Epub 2007 Aug 23. Breast. 2007. PMID: 17719225 Review.
-
Renaming "chemobrain".Cancer Invest. 2007 Sep;25(6):373-7. doi: 10.1080/07357900701506672. Cancer Invest. 2007. PMID: 17882646 Review.
-
Neurocognitive changes in cancer survivors.Cancer J. 2008 Nov-Dec;14(6):396-400. doi: 10.1097/PPO.0b013e31818d8769. Cancer J. 2008. PMID: 19060604 Review.
-
Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.Psychooncology. 2006 Oct;15(10):921-30. doi: 10.1002/pon.1035. Psychooncology. 2006. PMID: 16477674
-
The potential for neuropsychology to inform functional outcomes research with breast cancer survivors.NeuroRehabilitation. 2006;21(1):51-64. NeuroRehabilitation. 2006. PMID: 16720938 Review.
Cited by
-
Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study.PLoS One. 2017 Nov 8;12(11):e0187165. doi: 10.1371/journal.pone.0187165. eCollection 2017. PLoS One. 2017. PMID: 29117210 Free PMC article.
-
5-Fluorouracil impairs attention and dopamine release in rats.Behav Brain Res. 2019 Apr 19;362:319-322. doi: 10.1016/j.bbr.2019.01.007. Epub 2019 Jan 7. Behav Brain Res. 2019. PMID: 30630020 Free PMC article.
-
Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment.Support Care Cancer. 2014 Jan;22(1):279-87. doi: 10.1007/s00520-013-2029-7. Epub 2013 Nov 10. Support Care Cancer. 2014. PMID: 24212261
-
Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin.ACS Chem Neurosci. 2016 Jun 15;7(6):689-99. doi: 10.1021/acschemneuro.5b00029. Epub 2016 May 22. ACS Chem Neurosci. 2016. PMID: 27145395 Free PMC article.
-
Measuring Clinical, Biological, and Behavioral Variables to Elucidate Trajectories of Patient-Reported Outcomes: The PROFILES Registry.J Natl Cancer Inst. 2022 Jun 13;114(6):800-807. doi: 10.1093/jnci/djac047. J Natl Cancer Inst. 2022. PMID: 35201353 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical